title: Drug development for cancer: implications for chemical modifiers.
authors.affiliation: Division of Cancer Treatment, National Cancer Institute, Bethesda, MD 20892.
authors.forename: B A
authors.initials: BA
authors.lastname: Chabner
authors.forename: D
authors.initials: D
authors.lastname: Shoemaker
mesh_terms: D000970:Antineoplastic Agents; D002626:Chemistry, Pharmaceutical; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D009316:National Institutes of Health (U.S.); D014481:United States
chemical_list: D000970:Antineoplastic Agents